The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia

Kardiologiya

Volumn 49, Issue 9, 2009, Pages 21-26

  Nikitina, N M ^a   Rebrov, A P ^a  

^a SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Atorvastatin; C reactive protein; Rheumatoid arthritis; Rigidity of arteries

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PYRROLE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADMINISTRATION, ORAL; ADULT; AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; PYRROLES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 74949143665     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pincus T., Sokka T., Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts: Arthritis Rheum 2001;44:1234-1236.
2. Maradit-Kremers H., Nicola P. J., Crowson C. S. et al. Cardiovascular death in rheumatoid arthritis: A population-based study. Arthrit Rheum 2005;52:722-732.
3. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Martin X. Rheumatoid Arthritis: The Disease Associated with Accelerated Atherogenesis. Semin Arthr Rheum 2005;35:8-17.
4. Carmona L., Balsa A., Gonzales I. et al. Prevalence of specific comorbid conditions in a nation-wied cohort of rheumatoid arthritis patients (Abstr.) The EULAR J 2001;60:148.
5. Santos M. J., Cordeiro A., Godinho et al. Increased prevalence of heart valve disease in RA (Abstr.) The EULAR J 2002;61:365.
6. Rosenson R. S. Myocardial injury: the acute phase response and lipoprotein metabolism J Am Coll Cardiol 1993;22:933-940.
7. Wallberg-Jonsson S., Dahlen G., Johnson O. et al. Lipoproteinlipase in relation to inflammatory activity in rheumatoid arthritis. J Intern Med 1996;240:373-380.
8. Lazarevic M. B., Vitic J., Myones B. L. et al. Antilipoprotein antibodies in rheumatoid arthritis. Semin Arthritis Rheum 1993;22:85-91.
9. Knopp R. H. Drug treatment of lipid disorders. New Engl J Med 1999;341:498-511.
10. Vaughan C. J., Gotto A. M., Basson C. T. The evolving role of statins in the management of atherosclerosis. J Am Col Cardiol 2000;35:1-10.
11. McCarey D. W., McInnes I. B., Madhok R. et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2004;63:1571-1575.
12. Hermann F., Forster A., Chenevard R. Simvastatin improves endothelial function in patients with rheumatoid arthritis. J Am Coll Cardiol 2005;45:461-464.
13. Arnett F. C., Edworthy S. M., Bloch D. A. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-324.
14. Thompson G. R. Handbook of hyperlipidemia. London: Current Science Ltd 1990.
15. Hladovec J. Circulating endothelial cells as a sign of vessel wall lesions. Physiol Bohemoslov 1978;27:140-144.
16. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol 2002;14:115-120.
17. Van Doomum S., McCol I. G., Wicks I. P. Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis. Arthritis Rheum 2002;46:862-875.
18. Cannon C. P., Braunwald E., McCabe C. H. et al. Comparison of intensive and Moderate Lipid Lovering with Statins after Acute Coronary Syndromes. N Engl J Med 2004;350:15-24.
19. Khush K. K., Waters D. Higher dose of potent statin better for highrisk patients. Cleveland Clinic J Med 2004;1:609-616.
20. Nissen S. E., Tuzcu E. M., Shoenhagen P. et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080.
21. Bergholm R., Leirisalo-Repo M., Vehkavaara S. et al. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Ateriol Thromb Vasc Biol 2002;22:1637-1641.
22. Vaudo G., Marchesi S., Gerli R. et al. endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004;63:31-35.
23. Gonzalez-Juanatey C., Testa A., Garcia-Castelo A. et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003;114:647-652.
24. Van Doomum S., McColl. G., Jenkins A. et al. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 2003;48:2700.
25. Arnett D. K., Evans G. W., Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994;140:669-682.
26. Hongo M., Tsutsui H., Mawatari E. et al. Fluvastatin improves arterial stiffness in patients with coronary artery disease and hyperlipidemia. Circ J 2008;72:722-728.
27. Ichihara A., Hayashi M., Koura Y. et al. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens 2005;19:103-109.
28. Van Doomum S., McColl G., Wicks I. P. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 2004;63:1571-1575.